The Biotech Sector is Positioned for a Big 2022 Rebound
The biotechnology sector was one of the worst underperformers in 2021, but this niche of the financial markets could see a big rebound in 2022.
The biotechnology sector was one of the worst underperformers in 2021, but this niche of the financial markets could see a big rebound in 2022.